Paternal Inflammatory Bowel Disease and the Risk of Pregnancy Loss
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Sonia Friedman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Division, Tufts Medical Center, Tufts University School of Medicine, Boston Massachusetts, USA. Hauptthemen laut MEDLINE: Fathers, Abortion, Spontaneous, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: the Aage and Johanne Louis-Hansens Foundation, Denmark..
Abstract (Originalsprache)
Background
Only about 30% of conceptions end in live births, yet there are little data on paternal causes of pregnancy loss. Men with inflammatory bowel disease may have multiple disease-related issues that may affect fertility. We aimed to examine pregnancy outcomes in women undergoing assisted reproduction whose male partners had Crohn’s disease or ulcerative colitis.
Methods
This nationwide study included all embryo transfers registered in the Danish Assisted Reproduction Registry from January 2, 2006, to September 3, 2019. The exposed cohort included embryo transfers from couples in which the male partners had Crohn’s disease or ulcerative colitis. The unexposed cohort included embryo transfers in which male partners did not have inflammatory bowel disease.
Results
For fathers with ulcerative colitis, the adjusted odds ratio for a positive biochemical pregnancy (positive human chorionic gonadotropin) was 1.14 (95% confidence interval [CI], 0.92-1.42), for a clinical pregnancy (positive vaginal ultrasonography at 7-8 weeks) was 0.91 (95% CI, 0.59-1.40), and for a live birth was 0.99 (95% CI, 0.71-1.60). For fathers with Crohn’s disease, the adjusted odds ratio for a biochemical pregnancy was 0.83 (95% CI, 0.63-1.09), for a clinical pregnancy was 0.58 (95% CI, 0.34-0.97), and for a live birth was 0.88 (95% CI, 0.51-1.55).
Conclusions
These findings may indicate that partners of men with Crohn’s disease may have an increased risk of early pregnancy loss. Future studies should confirm these results and examine the impact of paternal medications, paternal disease activity, and other factors associated with chronic inflammatory bowel disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology Division, Tufts Medical Center, Tufts University School of Medicine, Boston Massachusetts, USA.
- Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark.
- Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Center of Andrology and Fertility, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Sonia Friedman, Jens Fedder
Förderung
- the Aage and Johanne Louis-Hansens Foundation, Denmark.
Zitieren
APA
Friedman, S., Thorarinsson, C. T., Wod, M., Fedder, J., & Nørgård, B. M. (2025). Paternal Inflammatory Bowel Disease and the Risk of Pregnancy Loss. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae132
Vancouver
Friedman S, Thorarinsson CT, Wod M, Fedder J, Nørgård BM. Paternal Inflammatory Bowel Disease and the Risk of Pregnancy Loss. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae132
BibTeX
@article{Friedman2025,
author = {Friedman, Sonia and Thorarinsson, Caroline Thingholm and Wod, Mette and Fedder, Jens and Nørgård, Bente Mertz},
title = {Paternal Inflammatory Bowel Disease and the Risk of Pregnancy Loss},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae132}
}
EUVIMED